Skip to main content

ATPlite Luminescence Assay System 96-well, 300 Assay Points

ATP-monitoring luminescence assay for quantitative evaluation of proliferation and cytotoxicity of cultured mammalian cells.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Feature Specification
Application Cell Viability
Assay Points 300

ATP-monitoring luminescence assay for quantitative evaluation of proliferation and cytotoxicity of cultured mammalian cells.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Overview

ATP is a marker for cell viability because it is present in all metabolically active cells. Because ATP concentration declines rapidly when cells undergo necrosis or apoptosis, monitoring ATP is a good indicator of cytocidal, cytostatic and proliferation effects. Discover our ATPlite™ cell viability assay. Our ATPlite and ATPlite 1step luminescence assay systems use patented innovative technologies that measure cell viability, proliferation and cytotoxicity in mammalian cells based on the production of light caused by the reaction of ATP with added luciferase and D-luciferin.

ATPlite is an Adenosine TriPhosphate (ATP) monitoring system based on firefly (Photinus pyralis) luciferase. This luminescence cell viability assay is the alternative to colorimetric, fluorometric and radioisotopic assays for the quantitative evaluation of proliferation and cytotoxicity of cultured mammalian cells. ATP monitoring can be used to assess the cytocidal, cytostatic and proliferative effects of a wide range of drugs, biological response modifiers and biological compounds.

Advantages:

  • Long-lived luminescent signal: half-life (t1/2) greater than 5 hours, depending on cell type and medium
  • Rapid: results generated in 15 - 25 minutes
  • Simple and reproducible: no separation steps; only two reagent additions
  • Homogeneous assay: no cell harvesting or centrifugation required
  • Sensitive: down to 5 cells in 100µL medium (derived from CHO and HL-60 cells in 100µL medium)
  • Wide linear dynamic range: =105 (as derived from CHO and HL-60 cells)

Specifications

Application
Cell Viability
Assay Points
300
Automation Compatible
Yes
Brand
ATPlite
Cellular or Signaling Pathway
Autophagy
Cell Death
Cell Growth
Cytotoxicity
Necrosis
Cellular Process
Autophagy
Cell Death
Cell Growth
Cytotoxicity
Necrosis
Detection Modality
Luminescence
Format
Microplates
Protocol
2-step
Signal Halflife
At least 5 hours
Shipping Conditions
Shipped Ambient
Unit Size
300 (96-well) / 1200 (384-well)

Citations

Resources

Are you looking for resources, click on the resource type to explore further.

1-5 of 5 Resources
Application Note Icon
Application Note
ATPlite assay performance in human primary cells.

In this application note three ATP monitoring luminescence assays were assessed and compared head-to-head: (i) ATPlite™ from...

Flyer Icon
Flyer
Download your ATPlite flyer

Cytotoxicity, cell viability, and cell proliferation are important parameters to monitor when developing new therapeutics.

For...

Brochure Icon
Brochure
Get Our Brochure on Luminescence Assay Technology

Discover the cutting-edge of luminescence assay technology, offering unparalleled sensitivity and dynamic range for applications...

Application Note Icon
Application Note
Proliferation and cell death analyses of 3D cultures using Revvity CellCarrier Spheroid ULA microplates and ATPlite 3D products.

In the process of developing new therapeutic molecules, toxicity – whether it is to be avoided or whether it is desired – is an...

Flyer Icon
Flyer
Solutions to advance your CART-T cell research

Chimeric antigen receptor (CAR) T-cell therapy has transformed the field of immuno-oncology providing a novel approach to treating...

Scroll Icon